Tabula Rasa HealthCare Q2 Adj EPS $0.03 Beats $(0.14) Estimate, Sales $90.04M Beat $88.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
Tabula Rasa HealthCare (NASDAQ:TRHC) reported Q2 losses of $(0.38) per share, missing the analyst consensus estimate of $(0.14) by 171.43%. However, the company reported quarterly sales of $90.04 million, beating the estimate of $88.82 million by 1.37%. This represents a 24.02% increase over sales from the same period last year.
August 07, 2023 | 11:14 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Tabula Rasa HealthCare's Q2 earnings per share missed estimates, but sales exceeded expectations.
Tabula Rasa HealthCare's Q2 earnings per share missed estimates, which could negatively impact the stock. However, the company's sales exceeded expectations, which could offset the negative impact of the earnings miss. The net effect on the stock is uncertain in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100